Latest News & Updates
Breaking News
16 hours ago
Simantini Singh Deo
Other trending news you may like to read
Alithea Genomics Signs Deal with Revvity to Scale Transcriptomic Profiling for Drug Discovery
Alithea Genomics and Revvity partner to distribute MERCURIUS DRUG-seq, bringing scalable transcriptomic profiling into mainstream drug discovery screening.
Simantini Singh Deo
India's Bioeconomy Reaches $190 Billion After 20-Fold Growth Over 12 Years
India's bioeconomy has grown 20-fold to $190 billion in 12 years, with indigenous CAR-T therapy signalling upgraded GMP manufacturing capability.
Simantini Singh Deo
Sanofi's Tzield Gains FDA Accelerated Approval for Pediatric Stage 3 Type 1 Diabetes on C-Peptide Surrogate Endpoint
FDA grants accelerated approval to Tzield for pediatric Stage 3 T1D using C-peptide surrogate endpoint; boxed warning updated for viral reactivation.
Simantini Singh Deo
FDA Tightens Scrutiny of OTC Eye Drop Manufacturers Following Contamination-Linked Recalls
FDA's risk-based inspection framework is actively targeting ophthalmic manufacturers following a 2023–2024 contamination recall wave affecting multiple OTC eye drop brands.
Simantini Singh Deo
